
Socodka Daawooyinka daaweynta kansarka sanbabada ee Shiinaha waxay noqon kartaa mid adag. Tilmaamahani wuxuu bixiyaa dulmar guud oo ku saabsan daawooyinka caadiga ah, oo ay ku jiraan daaweynta la beegsanayo iyo immunotherapy, oo inta badan loo isticmaalo Shiinaha daaweynta kansarka sanbabada, oo ay weheliso macluumaadka ku saabsan tijaabooyinka kiliinikada iyo helitaanka daaweyn cusub. Fahamka Daaweynta Kansarka Sambabada ee Shiinaha Kansarka sambabada waa walaac caafimaad oo muhiim ah Shiinaha, iyo hababka daaweynta ayaa si joogto ah u kobcaya. Fahamka noocyada kansarka sanbabada iyo fursadaha daawaynta ee jira ayaa muhiim u ah bukaanada iyo qoysaskooda. Noocyada Kansarka SambabadaLabada nooc ee ugu waaweyn ee kansarka sanbabada waa:Kansarka Sambabada Unug Yaryar (NSCLC): Kani waa nooca ugu badan, oo lagu qiyaaso 80-85% kiisaska kansarka sanbabada. Noocyada hoose waxaa ka mid ah adenocarcinoma, kansarka unugyada squamous, iyo kansarka unugyada waaweyn.Kansarka Sambabada Unug Yar (SCLC): Noocaan waa mid aad u yar oo u janjeera inuu u koro oo u faafo si ka dhaqso badan NSCLC. Hababka Daaweynta Caadiga ah ee daaweynta kansarka sanbabada ee Shiinaha sida caadiga ah waxay ku lug leedahay habab isku dhafan, oo ay ku jiraan: Qalliinka daaweynta shucaacaChemotherapyTargeted therapyImmunotherapy Daawooyinka kiimoterabiga caadiga ah ee Shiinaha looga isticmaalo kansarka sanbabada waxaa ka mid ah:Daawooyinka Platinum-ku-salaysan: Cisplatin, CarboplatinCanshuuraha: Paclitaxel, DocetaxelGemcitabineVinorelbinePemetrexedDaawooyinkan waxaa badanaa loo isticmaalaa isku-darka, nidaamka gaarka ah wuxuu ku xirnaan doonaa nooca iyo heerka kansarka sanbabada, iyo sidoo kale caafimaadka guud ee bukaanka. Daawooyinka Daawaynta La Beegsado ee Kansarka Sambabada ee Shiinaha Daawooyinka daawaynta la beegsaday waxay u shaqeeyaan iyaga oo bartilmaameedsanaya unugyo gaar ah oo ku lug leh koritaanka unugyada kansarka iyo fiditaanka. Daawooyinkan waxaa inta badan loo isticmaalaa NSCLC oo leh isbeddello hidde-side gaar ah.EGFR InhibitorsEGFR (reseptor factor factor receptor) inhibitors waxaa loo isticmaalaa bukaanada qaba NSCLC kuwaas oo leh isbeddellada EGFR. Kahortagayaasha caadiga ah ee EGFR ee laga heli karo Shiinaha waxaa ka mid ah:GefitinibErlotinibAfatiribOsimertinibALK InhibitorsALK (anaplastic lymphoma kinase) inhibitors ayaa loo isticmaalaa bukaanada qaba NSCLC kuwaas oo leh dib u habeynta hidda-wadaha ALK. Kahortagayaasha caadiga ah ee ALK ee laga heli karo Shiinaha waxaa ka mid ah:CrizotinibCertinibAlectinibDaawaynta Kale ee La Bartilmaameedsado Daawooyinka kale ee la beegsaday ayaa laga yaabaa in la isticmaalo iyadoo ku xidhan isbeddellada hidde-sidaha gaarka ah ee ku jira unugyada kansarka. Kuwaas waxaa ka mid ah:ROS1 horjoogayaasha: Loogu talagalay bukaanada leh dib u habeynta hidda-wadaha ROS1.Kahortayaasha BRAF: Loogu talagalay bukaannada qaba isbeddellada BRAF.Kahortagayaasha MET: Bukaanada qaba MET exon 14 oo ka boodaya isbedelada Daawooyinkan waxaa inta badan loo isticmaalaa NSCLC sare.PD-1/PD-L1 InhibitorsPD-1 (programmed cell death protein 1) iyo PD-L1 (barnaamijka dhimashada-ligand 1) inhibitors ayaa inta badan loo isticmaalaa daawooyinka immunotherapy. PD-1/PD-L1 horjoogayaasha caadiga ah ee laga heli karo Shiinaha waxaa ka mid ah:PembrolizumabNivolumabAtezolizumabDurvalumabSintilimabTislelizumabDaawooyinkan waxa loo isticmaali karaa kaligood ama lagu daro kiimoterabi. Tijaabooyinka Kiliiniga ee Kansarka Sambabada ee Shiinaha Tijaabooyinka kiliinikada waxay u fidiyaan bukaanada inay helaan daaweyn cusub oo cusub oo kansarka sanbabada ah. Isbitaalo badan iyo machadyo cilmi baaris oo ku yaal Shiinaha ayaa sameeya tijaabooyin caafimaad oo loogu talagalay kansarka sanbabada. Bukaan-socodka waxay ka raadin karaan tijaabooyin caafimaad iyagoo adeegsanaya mareegaha sida ClinicalTrials.gov iyo Diiwaanka Tijaabada Dawooyinka Shiinaha (中国药物临床试验登记与信息公示平台) .Gelitaanka Daawooyinka Kansarka Sambabada ee Shiinaha Gaadhida Daawooyinka daaweynta kansarka sanbabada ee Shiinaha way kala duwanaan kartaa iyadoo ku xidhan arrimo ay ka mid yihiin caymis caymis iyo habraacyada cusbitaalka. Daawooyin badan oo cusub ayaa hadda lagu daray Liiska Dawooyinka Lacag-celinta Qaranka (NRDL), taas oo si weyn u dhimi karta kharashka bukaanka. Waxaa lagu talinayaa inaad la tashato dhakhaatiirta kansarka iyo bixiyeyaasha daryeelka caafimaadka si loo fahmo fursadaha jira oo loo maro nidaamka daryeelka caafimaadka. Shandong Baofa Machadka Cilmi-baarista Kansarka (baofahospital.com) waxay u heellan yihiin horumarinta daaweynta kansarka iyo cilmi-baarista, hubinta in bukaannada ay helaan daawaynta ugu rajo-gelinta badan ee la heli karo, oo ay ku jiraan kuwa cusub Daawooyinka daaweynta kansarka sanbabada ee ShiinahaKharashaadka Daawaynta Kharashka daaweynta kansarka sanbabada waxay noqon kartaa walaac weyn. Fahmidda caymiska caymiska, barnaamijyada kaalmada maaliyadeed ee la heli karo, iyo NRDL waxay ka caawin karaan bukaanka inay maareeyaan kharashaadka daawaynta. Sahaminta fursadaha shaqaalaha bulshada iyo la-taliyayaasha maaliyadeed ee isbitaallada ayaa sidoo kale lagula talinayaa. Tixgelinta Daawooyinka Dhaqanka ee Shiinaha (TCM) Daawooyinka Shiineeska ee Dhaqanka (TCM) waxaa badanaa loo isticmaalaa daaweyn dhameystiran oo ay weheliso daaweynta kansarka sanbabada caadiga ah ee Shiinaha. Bukaanjiifka qaarkood waxay u arkaan TCM inay ku caawiso maaraynta waxyeelada iyo hagaajinta tayada nolosha. Si kastaba ha ahaatee, waa muhiim inaad kala hadasho isticmaalka TCM dhakhtarkaaga kansarka si aad u hubiso inay badbaado tahay oo aanay faragelin qorshahaaga daawaynta caadiga ah. Saamaynnada Daawaynta ee suurtogalka ah iyo Maaraynta Daawooyinka kansarka sambabada waxay sababi karaan waxyeelooyin, kuwaas oo kala duwan iyadoo ku xidhan daroogada gaarka ah. Dhibaatooyinka caadiga ah waxaa ka mid ah daal, lallabbo, matag, shuban, iyo finan maqaarka ah. Maareynta dhibaatooyinka soo raaca waa qayb muhiim ah oo ka mid ah habka daaweynta. Kooxdaada daryeelka caafimaadku waxay ku siin karaan hagis ku saabsan sida loo maareeyo dhibaatooyinka soo raaca oo loo wanaajiyo tayada noloshaada. Horumarradii ugu dambeeyay ee Daaweynta Kansarka Sambabada ee Shiinaha Qaybta daaweynta kansarka sanbabada ayaa si degdeg ah u kobcaysa. La soco wixii ku soo kordha Daawooyinka daaweynta kansarka sanbabada ee Shiinaha iyo hababka adiga oo la tashanaya bixiyaha xanaanada caafimaadkaaga iyo la socoshada suugaanta caafimaadka. Cilmi-baaris laga sameeyay machadyada sida Shandong Baofa Machadka Cilmi-baarista Kansarka ayaa si joogto ah uga qaybqaata saldhigga aqooneed ee sii kordhaya ee daaweynta kansarka. Soo koobida Daawooyinka Kansarka Sambabada ee Caadiga ah ee Shiinaha Shaxdani waxa ay soo koobaysaa dawooyinka caadiga ah ee loo isticmaalo daawaynta kansarka sanbabada ee Shiinaha. Nooca Daawada Tusaalooyinka Isticmaalka Caadiga ah ee Chemotherapy Cisplatin, Carboplatin, Paclitaxel, Gemcitabine Dila unugyada kansarka ee jirka oo dhan EGFR Inhibitors Gefitinib, Erlotinib, Osimertinib NSCLC oo leh EGFR beddelaadyada ALK Inhibitors Crizotinib, Ceritinib, Alectinib NSCarns Pembrolizumab, Nivolumab, Atezolizumab Advanced NSCLC; ka caawinta habka difaaca jirka si uu ula dagaallamo kansarka Afeef: Macluumaadkan waxaa loogu talagalay ujeeddooyin macluumaad oo keliya mana aha in loo tixgeliyo talo caafimaad. Had iyo jeer la tasho xirfadle daryeel caafimaad oo u qalma ogaanshaha iyo daawaynta kansarka sanbabada. La tasho dhakhtarkaaga ka hor intaadan samayn wax go'aan ah oo la xidhiidha daawayntaada ama daryeelkaaga. Had iyo jeer raadso talada khabiirka caafimaadka wixii su'aalo ah ee ku saabsan xaaladahaaga gaarka ah.